NuGen Medical DevicesNGMDF EV-to-EBITDA is -2.87 as of Jul. 13, 2026. The stock has 7 warning signs investors should review. Among 513 Medical Devices & Instruments companies, NuGen Medical Devices ranks worse than 194931.58% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, NuGen Medical Devices's enterprise value is $14.53 Mil.
NuGen Medical Devices's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-5.07 Mil. Therefore, NuGen Medical Devices's EV-to-EBITDA for today is -2.87.
The historical rank and industry rank for NuGen Medical Devices's EV-to-EBITDA or its related term are showing as below:
NGMDF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -254.94 Med: -4.59 Max: 23.23
Current: -2.95
During the past 6 years, the highest EV-to-EBITDA of NuGen Medical Devices was 23.23. The lowest was -254.94. And the median was -4.59.
NGMDF's EV-to-EBITDA is ranked worse than 100% of 513
companies
in the Medical Devices & Instruments industry
Industry Median: 14.17
vs NGMDF: -2.95
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
NuGen Medical Devices (OTCPK:NGMDF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
NuGen Medical Devices's PE Ratio (TTM) for today is calculated as:
NuGen Medical Devices's share price for today is $0.01565.
NuGen Medical Devices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.043.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
NuGen Medical Devices EV-to-EBITDA Historical Data
* Premium members only.
The historical data trend for NuGen Medical Devices's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, NuGen Medical Devices's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NuGen Medical Devices EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NuGen Medical Devices's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where NuGen Medical Devices's EV-to-EBITDA falls into.
NuGen Medical Devices's current Enterprise Value is $14.53 Mil.
NuGen Medical Devices's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.07 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NuGen Medical Devices (NGMDF) has a EV-to-EBITDA of -2.87 as of Jul. 13, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on NuGen Medical Devices. According to the industry distribution chart, NuGen Medical Devices ranks #999999 out of 513 companies in the Medical Devices & Instruments industry.
Is NuGen Medical Devices' EV-to-EBITDA too high?
NuGen Medical Devices' current EV-to-EBITDA is -2.87. Based on the distribution chart, NuGen Medical Devices ranks #999999 out of 513 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does NuGen Medical Devices' EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, NuGen Medical Devices ranks #999999 out of 513 companies for EV-to-EBITDA. This places NuGen Medical Devices in the lower half of its industry. The industry median EV-to-EBITDA is 14.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.17, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on NuGen Medical Devices. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NuGen Medical Devices's current EV-to-EBITDA is -2.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NuGen Medical Devices stock overvalued right now?
Based on GuruFocus' analysis, NuGen Medical Devices (NGMDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.02, compared to a current price of $0.02 — trading 21.8% below its estimated fair value. The current EV-to-EBITDA is -2.87. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For NuGen Medical Devices (NGMDF), the current EV-to-EBITDA is -2.87 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needle injector devices. Geographically, the company generates revenue from Europe, followed by Asia, and other.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGMDF has been successfully added to your 